Key result
Esmolol raises the ventricular fibrillation threshold nearly fourfold in preclinical models.
Why the study?
The effect of esmolol on the ventricular fibrillation threshold (VFT) and its dependence on the method used to test fibrillation vulnerability was unclear.
Does esmolol increase the ventricular fibrillation threshold in open-chest dogs?
Does esmolol increase the ventricular fibrillation threshold in open-chest dogs?
Answers are grounded in this paper and cite their sources.
Esmolol increases the ventricular fibrillation threshold in a canine model when measured by a train-of-pulses technique, demonstrating its antiarrhythmic potential via beta-blockade.
The effect of esmolol on the ventricular fibrillation threshold (VFT) was determined in 11 open-chest dogs anesthetized with sodium pentobarbital. Since changes in VFT by antiarrhythmic drugs have been shown to depend on the method used to test vulnerability to fibrillation, two methods were studied. The vulnerable period was scanned with a train of pulses (100 Hz, 4 ms, 20 pulses) in nine experiments and a single pulse (10 ms) in eight experiments. Following control measurements, esmolol was administered as an intravenous bolus of 500 micrograms/kg followed by a continuous infusion of 300 micrograms/kg/min. After 15 min of infusion, the adequacy of beta-blockade was tested by the administration of 0.5 micrograms/kg of isoproterenol. Isoproterenol increased the heart rate by only 18 +/- 2 beats/min following esmolol administration which was significantly less than the control response (79 +/- 7 beats/min, p less than 0.01). Although the VFT measured with the single-pulse technique did not change in response to esmolol (14.1 +/- 1.1 mA vs. 14.3 +/- 1.2 mA), the VFT measured with the train-of-pulses technique significantly increased (3.7 +/- 0.5 mA to 14.5 +/- 2.8 mA, p less than 0.01). Twenty minutes after discontinuing esmolol, the VFT measurements were repeated and did not differ from control values with either technique. The increase in heart rate in response to isoproterenol also returned to control values (80 +/- 6 beats/min). The results suggest that the ability of esmolol to raise VFT as measured by the train-of-pulses technique is due to beta-adrenergic blockade.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Wallis et al. (2008) studied this question. Esmolol vs. Control measurements was evaluated on Ventricular fibrillation threshold (VFT) measured with the train-of-pulses technique (p=<0.01). Esmolol increased the ventricular fibrillation threshold measured with the train-of-pulses technique from 3.7 mA to 14.5 mA in anesthetized dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: